Cargando…

Cyclical Combination Chemotherapy in Advanced Breast Cancer

Results with cyclical combination chemotherapy in advanced breast cancer are presented. The overall remission rate, 79 per cent, is superior to that obtained by two conventional endocrine procedures, administration of norethisterone acetate and hypophysectomy. The advantage is especially pronounced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edelstyn, G. A., Macrae, K. D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1973
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008915/ https://www.ncbi.nlm.nih.gov/pubmed/4758373

Ejemplares similares

Thiotepa in the treatment of advanced breast cancer.
por: Lyons, A. R., et al.
Publicado: (1965)

Thyroid Hormone as a Prophylactic Agent Following Radical Treatment of Breast Cancer
por: Lyons, A. R., et al.
Publicado: (1965)

Neoadjuvant chemotherapy in combination with surgery in the treatment of local advanced breast cancer
por: Zhao, Haixia, et al.
Publicado: (2019)

Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free Survival
por: Maly, Joseph J, et al.
Publicado: (2014)

Chemotherapy of advanced breast cancer: outcome and prognostic factors.
por: Gregory, W. M., et al.
Publicado: (1993)

Combination chemotherapy for advanced colorectal cancer
por: Mason, M, et al.
Publicado: (2003)

Do patients with advanced breast cancer benefit from chemotherapy?
por: Ramirez, A. J., et al.
Publicado: (1998)

Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study
por: Zhu, Anjie, et al.
Publicado: (2019)

Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
por: Yulian, Erwin Danil, et al.
Publicado: (2021)

Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination.
por: Rubens, R. D., et al.
Publicado: (1975)

First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.
por: Athanassiou, A. E., et al.
Publicado: (1989)

Regional Hyperthermia Combined with Chemotherapy in Advanced Gastric Cancer
por: Fang, Hongming, et al.
Publicado: (2019)

Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer.
por: de Graaf, H., et al.
Publicado: (1997)

Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer
por: Hackshaw, A, et al.
Publicado: (2005)

Cyclic AMP binding proteins and prognosis in breast cancer.
por: Miller, W. R., et al.
Publicado: (1990)

Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study
por: Bartsch, Rupert, et al.
Publicado: (2006)

Efficacy and Safety of Cinobufacin Combined with Chemotherapy for Advanced Breast Cancer: A Systematic Review and Meta-Analysis
por: Xu, Jing, et al.
Publicado: (2020)

Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?
por: Grunfeld, E A, et al.
Publicado: (2001)

Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer
por: CUI, HAI-BIN, et al.
Publicado: (2014)

Cyclic AMP binding proteins in human breast cancer.
por: Miller, W. R., et al.
Publicado: (1985)

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer
por: Gatti-Mays, Margaret E., et al.
Publicado: (2021)

Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer
por: Baek, J H, et al.
Publicado: (2006)

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.
por: Fraser, S. C., et al.
Publicado: (1993)

Efficacy of Combination Neoadjuvant Chemotherapy and Regional Inductive Moderate Hyperthermia in the Treatment of Patients With Locally Advanced Breast Cancer
por: Loboda, Anton, et al.
Publicado: (2020)

MGBG–cisplatin combination chemotherapy against breast cancer
por: Gonsalves, Raquel F, et al.
Publicado: (2010)

Immunotherapy Combined with Chemotherapy in Relapse Metaplastic Breast Cancer
por: Chen, Ling, et al.
Publicado: (2023)

Advances in Cancer Chemotherapy
por: Crowther, D.
Publicado: (1979)

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity
por: Torrisi, R, et al.
Publicado: (2008)

Changes in allelic imbalances in locally advanced breast cancers after chemotherapy
por: Varna, M, et al.
Publicado: (2007)

A review of topotecan in combination chemotherapy for advanced cervical cancer
por: Robati, Minoo, et al.
Publicado: (2008)

Role of Scintimammography in Assessing the Response of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
por: Trehan, Romeeta, et al.
Publicado: (2014)

Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
por: Sugiyama, T, et al.
Publicado: (1999)

Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters
por: McDonnell, Alison M., et al.
Publicado: (2017)

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
por: Tsavaris, N, et al.
Publicado: (2002)

Possible Clinical Implications of Therapeutically Induced Temperature Changes in Continuously Monitored Tumour mass: (Preliminary Report)
por: Gillespie, P. J., et al.
Publicado: (1971)

Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
por: Sultana, Asma, et al.
Publicado: (2008)

The Efficacy of Radiofrequency Hyperthermia Combined with Chemotherapy in the Treatment of Advanced Ovarian Cancer
por: Li, Zhihui, et al.
Publicado: (2018)

Immune gene expression and response to chemotherapy in advanced breast cancer
por: Foukakis, Theodoros, et al.
Publicado: (2018)

The Status of Chemotherapy in Metastatic Breast Cancer: Insights for the Advanced Practitioner
por: Hanna, Kirollos, et al.
Publicado: (2021)

New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
por: An, Junsha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_osm7poc8fl6euoo35450so7k6b